Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-15

Clinical Trial Update: Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing cabazitaxel combined with radiation and hormone therapy for prostate cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jevtana (cabazitaxel)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED